The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Safety of pertussis vaccination in pregnant women in UK: observational study
Open accessAbstract
OBJECTIVE: To examine the safety of pertussis vaccination in pregnancy. DESIGN: Observational cohort study. SETTING: The UK Clinical Practice Research Datalink. PARTICIPANTS: 20,074 pregnant women with a median age of 30 who received the pertussis vaccine and a matched historical unvaccinated control group. MAIN OUTCOME MEASURE: Adverse events identified from clinical diagnoses during pregnancy, with additional data from the matched child record identified through mother-child linkage. The primary event of interest was stillbirth (intrauterine death after 24 weeks' gestation). RESULTS: There was no evidence of an increased risk of stillbirth in the 14 days immediately after vaccination (incidence rate ratio 0.69, 95% confidence interval 0.23 to 1.62) or later in pregnancy (0.85, 0.44 to 1.61) compared with historical national rates. Compared with a matched historical cohort of unvaccinated pregnant women, there was no evidence that vaccination accelerated the time to delivery (hazard ratio 1.00, 0.97 to 1.02). Furthermore, there was no evidence of an increased risk of stillbirth, maternal or neonatal death, pre-eclampsia or eclampsia, haemorrhage, fetal distress, uterine rupture, placenta or vasa praevia, caesarean delivery, low birth weight, or neonatal renal failure, all serious events that can occur naturally in pregnancy. CONCLUSION: In women given pertussis vaccination in the third trimester, there is no evidence of an increased risk of any of an extensive predefined list of adverse events related to pregnancy. In particular, there was no evidence of an increased risk of stillbirth. Given the recent increases in the rate of pertussis infection and morbidity and mortality in neonates, these early data provide initial evidence for evaluating the safety of the vaccine in pregnancy for health professionals and the public and can help to inform vaccination policy making.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES
Abramson, J. S., Pickering, L., Gilsdorf, J. R., Dunne, E. M., Lawson, H. W., Dubin, G. O., Barr, E., Chesson, H. W., Garnett, G. P., & Markowitz, L. E. (2006) · Cited by 932
Effectiveness of maternal pertussis vaccination in England: an observational study
Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., Fry, N. K., Miller, E., & Ramsay, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60686-3 · Cited by 739
Self-citationSawyer, M., Liang, J. L., Messonnier, N. E., & Clark, T. A. (2013) · MMWR Morbidity and Mortality Weekly Report · Cited by 722
Eclampsia in the United Kingdom 2005
Knight, M. (2007) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01423.x · Cited by 275
Recent developments in pertussis
Crowcroft, N. S., & Pebody, R. G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68848-x · Cited by 256
Gall, S. A., Myers, J., & Pichichero, M. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.11.024 · Cited by 226
Outcomes of severe pre‐eclampsia/eclampsia in Yorkshire 1999/2003
Tuffnell, D. J., Jankowicz, D., Lindow, S. W., Lyons, G., Mason, G. C., Russell, I. F., Walker, J. J., & On behalf of the Yorkshire Obstetric Critical Care Group (2005) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00565.x · Cited by 183
Zheteyeva, Y. A., Moro, P. L., Tepper, N. K., Rasmussen, S. A., Barash, F., Revzina, N., Kissin, D. M., Lewis, P. W., Yue, X., Haber, P., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.05.006 · Cited by 111
Cited by
Effectiveness of maternal pertussis vaccination in England: an observational study
Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., Fry, N. K., Miller, E., & Ramsay, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60686-3 · Cited by 739
Self-citationQuinn, J.-A., Munoz, F. M., Gonik, B., Frau, L., Cutland, C., Mallett-Moore, T., Kissou, A., Wittke, F., Das, M., Nunes, T., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.045 · Cited by 497
Liang, J. L., Tiwari, T., Moro, P., Messonnier, N. E., Reingold, A., Sawyer, M., & Clark, T. A. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6702a1 · Cited by 457
Pertussis: Microbiology, Disease, Treatment, and Prevention
Kilgore, P. E., Salim, A. M., Zervos, M. J., & Schmitt, H.-J. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00083-15 · Cited by 434
Dabrera, G., Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Fry, N. K., & Ramsay, M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu821 · Cited by 385
Amirthalingam, G., Campbell, H., Ribeiro, S., Fry, N. K., Ramsay, M., Miller, E., & Andrews, N. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw559 · Cited by 275
Vaccination of special populations: Protecting the vulnerable
Doherty, M., Schmidt-Ott, R., Santos, J. I., Stanberry, L. R., Hofstetter, A. M., Rosenthal, S. L., & Cunningham, A. L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.015 · Cited by 208
Sukumaran, L., McCarthy, N. L., Kharbanda, E. O., McNeil, M. M., Naleway, A. L., Klein, N. P., Jackson, M. L., Hambidge, S. J., Lugg, M. M., Li, R., et al. (2015) · JAMA · doi:10.1001/jama.2015.12790 · Cited by 112
Prenatal Tdap immunization and risk of maternal and newborn adverse events.
Layton, J. B., Butler, A. M., Li, D., Boggess, K. A., Weber, D. J., McGrath, L. J., & Becker-Dreps, S. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.071 · Cited by 60
Metadata
- Authors
- Donegan, K., King, B., & Bryan, P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2014-07-11
- Volume
- 349
- Issue
- jul11 1
- Pages
- g4219-g4219
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2157166000
- Cited by
- 281
- References
- 15
- FWCI
- 29.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.